Register for email alerts and news feeds:
This journal | BMJ Group
rss
Drug and Therapeutics Bulletin 1995;33:77-79; doi:10.1136/dtb.1995.331077
Copyright © 1995 by the BMJ Publishing Group Ltd.

Giving erythromycin by mouth

Relevant BNF section: 5.1.5

Erythromycin is a broad spectrum macrolide antibiotic. In the UK, it is available in over 15 oral preparations, presented as tablets, capsules, suspensions or granules containing the drug as erythromycin base, as the stearate salt, or as an ester. How the drug is formulated affects the absorption and bioavailability of erythromycin, so could in theory influence its effectiveness and the incidence of unwanted effects. We review the different oral preparations and consider whether the choice of formulation matters in practice.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • McNulty, C. A. M., Kane, A., Foy, C. J. W., Sykes, J., Saunders, P., Cartwright, K. A. V. (2000). Primary care workshops can reduce and rationalize antibiotic prescribing. J Antimicrob Chemother 46: 493-499 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for email alerts

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Coming soon!

The DTB archive back to 1962, volume 1, issue 1 will soon be available.